BridgeBio Pharma, Inc. (BBIO)
NASDAQ · Healthcare
BridgeBio Pharma, Inc. Total Assets 2019–2025
BridgeBio Pharma, Inc. annual total assets history from 2019 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
- BridgeBio Pharma, Inc. total assets as of December 31, 2025: 936.0M, a 1.82% increase year-over-year.
- BridgeBio Pharma, Inc. total assets for 2025 were 936.0M, a 1.82% increase from 2024.
- BridgeBio Pharma, Inc. total assets for 2024 were 919.3M, a 68.26% increase from 2023.
- BridgeBio Pharma, Inc. total assets for 2023 were 546.4M, a 12.30% decrease from 2022.
- BridgeBio Pharma, Inc. total assets for 2022 were 623.0M.
Total Assets
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| BridgeBio Pharma, Inc. Annual Total Assets (Millions of US $) | |
|---|---|
| 2025 | $936 |
| 2024 | $919 |
| 2023 | $546 |
| 2022 | $623 |
| 2021 | $1,013 |
| 2020 | $704 |
| 2019 | $632 |
BridgeBio Pharma, Inc. Total Assets — FAQ
BridgeBio Pharma, Inc. (BBIO) total assets over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BBIO's total assets history?
The chart and table above show BridgeBio Pharma, Inc.'s total assets by year and by quarter, including the growth rate.